Statins Linked to Lower Glaucoma Risk
New research finds people taking statins are less likely to develop glaucoma and need fewer eye procedures.
Updated on Nov. 3, 2026 in Stroke
A study published in the British Journal of Ophthalmology found that people taking statins have a lower risk of developing open-angle glaucoma, and glaucoma patients taking statins needed fewer surgeries, laser procedures, and eye drops. The analysis drew on data from more than 200,000 statin users older than 40.
Why it matters
Glaucoma remains the number one cause of irreversible blindness in the world, so a low-cost existing drug linked to reduced risk could matter for prevention. Researchers point to prior findings that statins have anti-inflammatory, immune-modulating, and neuroprotective properties.
Among nearly 280,000 glaucoma patients, statin users were 60% less likely to need an in-office laser procedure, 55% less likely to need minimally invasive surgery, and 36% less likely to undergo conventional surgery. Whether these procedure differences reflect a direct treatment effect has not been established.
The players
UC San Diego
The University of California, San Diego is a public research university, and the institution of the senior study author.
Life Biosciences
Life Biosciences is a biotechnology company studying an epigenetic therapy for retinal ganglion cells in glaucoma patients.
The details
Researchers compared statin users against a control group of the same size and reported that statin use was also linked to a reduced need for daily pressure-lowering eye drops. Cardiovascular factors such as high cholesterol, hypertension, and diabetes are known to influence glaucoma risk.
Timeline
The study measured glaucoma risk over 5 years and over a decade among statin users.
Health Landscape
The research extends earlier work on statins' anti-inflammatory and neuroprotective properties into eye disease, an area where treatment has largely centered on lowering eye pressure. If future clinical trials confirm a protective role, doctors could gain a roadmap for adding statins to vision-saving regimens.
Glaucoma patients should continue prescribed eye treatments, since the study does not establish that statins replace them. Anyone considering statin therapy should discuss cardiovascular and eye health risks with a clinician.
The takeaway
Statins may offer a possible complementary benefit for glaucoma, but confirmation requires clinical trials before any change in care.
Further reading
Explore more on Stroke and related cardiovascular health topics.
Source note: This article includes information reported by Medscape.
